About this Research Topic
Since the first use in 1996 by John E. McGowan Jr. and Dale N. Gerding the term “Antimicrobial Stewardship” (AMS) has grown exponentially in recent years. The objective was to highlight antimicrobials as a precious and non-renewable resource, using a concept that encompassed rational use, moving away from the concept of cost containment, which had prevailed until then.
Choosing the optimal antibiotic dose includes the pathogen’s minimum inhibitory concentration, site, and severity of infection; also, the patient volume of distribution, renal clearance, weight, and organ support should be considered. Application of pharmacokinetic/pharmacodynamic (PK/PD) concepts in antimicrobial prescription are a stone in AMS programs.
This Research Topic proposes a set of articles to highlight the importance of PK/PD:
- The importance of PK/PD on antimicrobial stewardship
- How TDM can improve antimicrobial stewardship?
- Designing the optimal dose of aminoglycosides in gram-negative infections.
- Vancomycin TDM for every patient? Breaking rules.
- Beta-lactam TDM, the next barrier to cross.
- Achieving optimal antimicrobial dose in ICU care.
Keywords: Pharmacokinetic, pharmacodynamic, antimicrobial stewardship, therapeutic drug monitoring, optimal antimicrobial dose, rational antimicrobial prescription
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.